MedTrace Logo

Effects of PeptiSleep in Healthy Males and Females With Mild to Moderate Sleep Impairment

NCT06267586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-03-13

No results posted yet for this study

Summary

Examining the effects of PeptiSleep, a plant-based sleep aid, in healthy males and females with mild to moderate sleep impairment

Conditions

  • Sleep

Interventions

DIETARY_SUPPLEMENT

PeptiSleep

Plant protein hydrolysate

DIETARY_SUPPLEMENT

Placebo MCC micro-crystalline cellulose

Placebo MCC micro-crystalline cellulose

Sponsors & Collaborators

  • RDC Clinical Pty Ltd

    collaborator INDUSTRY

  • Nuritas Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-08
Primary Completion
2024-12-30
Completion
2025-03-01

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06267586 on ClinicalTrials.gov